Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/10/2026 | Q4 | $398.1K | -- | -- | -$1.04 | -- |
| 11/05/2025 | Q3 | $523.6K | $396K | -$0.97 | -$0.90 | -$0.07 |
| 08/08/2025 | Q2 | $864.7K | $193K | -$0.88 | -$0.87 | -$0.02 |
| 05/08/2025 | Q1 | $806.9K | $1.2M | -$0.82 | -$0.71 | -$0.11 |
| 03/11/2025 | Q4 | $859.7K | $1.3M | -$0.81 | -$0.76 | -$0.05 |
| 11/07/2024 | Q3 | $576.4K | $2.2M | -$0.74 | -- | -- |
| 08/08/2024 | Q2 | $322.8K | $1.9M | -$0.51 | -- | -- |
| 05/09/2024 | Q1 | $371.4K | $874K | -$0.54 | -- | -- |
| 03/21/2024 | Q4 | $438.8K | $457K | -$0.71 | -- | -- |
| 11/09/2023 | Q3 | $250K | $924K | -$3.78 | -- | -- |
| 06/30/2023 | Q2 | -- | $969K | -$12.73 | -- | -- |
| 03/31/2023 | Q1 | -- | $476K | -$129.67 | -- | -- |
| 12/31/2022 | Q4 | -- | $1.2M | -$11.57 | -- | -- |
| 09/30/2022 | Q3 | -- | $1.2M | -$142.45 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$4.70 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$6.25 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$5.25 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$4.76 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$5.04 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$5.76 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$5.99 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$5.86 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$7.71 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$8.13 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$9.52 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$8.65 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$7.73 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$7.10 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$8.04 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$7.77 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$50.09 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$5.05 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$3.13 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$6.96 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$2.34 | -- | -- |
Dianthus Therapeutics, Inc. reported $396K worth of top line sales in its most recent quarter.
Dianthus Therapeutics, Inc. announced earnings per share of -$0.97 which represents a miss of analyst forecast a -$0.90 per share.
Dianthus Therapeutics, Inc. reported $297K that represents $0.01 per share over the last quarter.
Dianthus Therapeutics, Inc.'s earnings are forecast to decrease from -$2.55 per share to -$2.27 per share next year representing a decrease of -38.79%.
Dianthus Therapeutics, Inc.'s next earnings date is March 10, 2026.
Signup to receive the latest stock alerts
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Market Cap: $4.5T
P/E Ratio: 63x
Market Cap: $4T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
UniFirst Corp. [UNF] is up 0.77% over the past day.